Tech Company Financing Transactions

Reverb Therapeutics Funding Round

Amplitude Ventures, InBC Investment and KdT Ventures participated in a $12 million Seed venture round for Reverb Therapeutics. The round was announced by the company on 2/19/2025.

Transaction Overview

Announced On
2/19/2025
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Undisclosed
Vancouver, BC, Undisclosed
Canada
Phone
Undisclosed
Email Address
Overview
Reverb Therapeutics Developing Bispecific Antibodies that exploit the therapeutic potential of the natural immune system.
Profile
Reverb Therapeutics LinkedIn Company Profile
Social Media
Reverb Therapeutics Company Twitter Account
Company News
Reverb Therapeutics News
Facebook
Reverb Therapeutics on Facebook
YouTube
Reverb Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David De Graaf
  David De Graaf LinkedIn Profile  David De Graaf Twitter Account  David De Graaf News  David De Graaf on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/19/2025: Mavvrik venture capital transaction
Next: 2/19/2025: EnPlusOne Biosciences venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary